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論文の内容の要旨 
論文題目：Mucolipin-1 positively regulates TLR7 responses in dendritic cells by facilitating single 
stranded RNA transportation to lysosomes 
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  Toll-like receptors (TLR) 7and 9 erroneously respond to self-derived nucleic acids 
(NAs) and cause autoimmune diseases like systemic lupus erythematosus (SLE) and 
rheumatoid arthritis (RA). Mechanisms that restrict RNA/DNA-sensing in 
endolysosomes avoid recognition of self-derived pathogen by TLR7 or TLR9. Aberrant 
transportation of self-derived RNA/DNA to endolysosomes has been shown to 
exacerbate autoimmunity. To limit NAs-sensing by TLR7 or TLR9 in endolysosomes, 
TLR7/9 transportation is tightly controlled by Unc93B1, which is a multiple 
transmembrane protein that is associated with TLR7/9 and transports them from ER to 
endolysosomes. 
  When compared to sensors transportation, much less is known about molecular 
mechanisms underlying NAs transportation. PIKfyve, a phosphatidylinositol 
3-phosphate 5-kinase, is shown to be required for CpG-B translocation from early 
endosome to late endosomes. PIKfyve synthesizes PtdIns(3,5)P2, suggesting a role of 
PtdIns(3,5)P2 in DNA trafficking. PtdIns(3,5)P2 is reported to directly bind to 
mucolipin-1 and induce Ca2+ release. Mucolipin-1, a member of the transient receptor 
potential (TRP) cation channel family, primarily localizes on the lysosome membrane 
and has a role in regulating lysosomal trafficking. Considering that Mucolipin-1 is a 
target of PtdIns(3,5)P2 and has a role in endolysosomal trafficking, Mucolipin-1 may 
have a role in NAs trafficking in innate immune cells. To address this issue, TLR7 and 
TLR9 responses in Mcoln1-/- mice were studied.  
  Mcoln1-/- BM-cDCs and BM-pDCs were significantly impaired in the TLR7 
responses to ssRNAs (RNA9.2s-DR and Poly U). The synthetic mucolipin agonist 
(ML1-SA1) specifically enhanced TLR7 responses to ssRNA. These results suggest that 
mucolipin-1 has a role in TLR7 responses to ssRNA. Because mucolipin-1 is activated 
by a PtdIns(3,5)P2, which is generated by PIKfyve, the effect of PIKfyve inhibitor 
YM201636 on TLR responses in BM-cDCs and BM-pDCs was next studied. TLR7 
responses to RNA9.2s-DR or Poly U were diminished in the presence of PIKfyve 
inhibitor YM201636. These data suggest that the PtdIns(3,5)P2 –mucolipin-1 axis has an 
important role in TLR7 responses to ssRNA.  
Previous studies show that mucolipin-1 regulates endocytosis. However, Mcoln1-/- 
BM-cDCs did not show any impairment in ssRNA internalization. PIKfyve is shown to 
have a role in DNA transportation. To gain insight into roles of the 
PtdIns(3,5)P2-mucolipin-1 axis in regulating ssRNA transportation, confocal 
microscopy experiments were conducted. Colocalization of ssRNA ligands with a 
lysosome marker was significantly impaired in Mcoln1-/- BM-cDCs. ML1-SA1 
significantly enhanced the ssRNA transportation to lysosomes. Moreover, PIKfyve 
inhibitor drastically impaired the ssRNA transportation to lysosomes. These results 
demonstrated that ssRNA trafficking into lysosomes is mediated by the 
PtdIns(3,5)P2-Mucolipin-1 axis. 
  Mcoln1-/- BM-cDCs and BM-pDCs showed impaired responses to small chemical 
TLR7 ligands. Neither mucolipin agonist nor PIKfyve inhibitor altered TLR7 responses 
to these small chemical ligands, suggesting that mucolipin-1 has another role in TLR7 
responses in addition to the role downstream of PIKfyve. The underlying mechanisms 
are necessary to be further researched. 
  In Mcoln1-/- BM-cDCs and BM-pDCs, TLR9 responses to CpG-B were not altered, 
mucolipin agonist did not enhance TLR9 in responses to CpG-B. Co-localization of 
CpG-B with a lysosome marker was not altered in Mcoln1-/- BM-cDCs. Consistent with 
the previous report, PIKfyve inhibitor altered TLR9 responses to CpG-B. These results 
indicate that TLR9 response to CpG-B responses do not require mucolipin-1. It is 
possible that other downstream effectors of PtdIns(3,5)P2 have roles in regulating TLR9 
responses to CpG-B.  
  TLR9 responses to CpG-A were decreased in Mcoln1-/- DCs or by treatment of 
PIKfyve inhibitor. On the other hand, mucolipin agonist ML1-SA1 did not enhance, but 
significantly impaired CpG-A responses in BM-cDCs. Confocal microscopy showed 
that in the presence of ML1-SA1, transportation of CpG-A to lysosome is impaired. 
These results suggest that mucolipin family members other than mucolipin 1 negatively 
regulate CpG-A trafficking into lysosomes. A role of mucolipin-1 in CpG-A responses 
has to be addressed in further study. PIKfyve inhibitor drastically inhibited the CpG-A 
transportation to lysosomes, suggesting that as yet unknown effectors downstream of 
PIKfyve may regulate CpG-A trafficking. 
  Finally, to address the immunogical relevance of mucolipin-1 in in vivo innate 
immune responses, R848 was injected into BM chimeric mice reconstituted by 
Mcoln1-/- bone marrow cells. Production of IL-6 and IL-12p40 showed significant 
impairment when compared with BM chimeric mice reconstituted with WT BM cells. 
These results further demonstrate the importance of mucolipin-1 in TLR7 responses in 
vivo. 
  In conclusion, the PtdIns(3,5)P2-Mucolipin-1 axis has an important role in ssRNA 
transportation to lysosome, but not DNA transportation to lysosomes. Transportation of 
DNA and RNA is differentially regulated.  
